AAAAAA

   
Results: 1-25 | 26-50 | 51-51
Results: 1-25/51
Patterns of HER-2/neu amplification and overexpression in primary and metastatic breast cancer
Authors: Simon, R Nocito, A Hubscher, T Bucher, C Torhorst, J Schraml, P Bubendorf, L Mihatsch, MM Moch, H Wilber, K Schotzau, A Kononen, J Sauter, G
Citation: R. Simon et al., Patterns of HER-2/neu amplification and overexpression in primary and metastatic breast cancer, J NAT CANC, 93(15), 2001, pp. 1141-1146
Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings
Authors: Bubendorf, L Grilli, B Sauter, G Mihatsch, MJ Gasser, TC Dalquen, P
Citation: L. Bubendorf et al., Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings, AM J CLIN P, 116(1), 2001, pp. 79-86
Tissue microarrays: What will they bring to molecular and anatomic pathology?
Authors: Moch, H Kononen, J Kallioniemi, OP Sauter, G
Citation: H. Moch et al., Tissue microarrays: What will they bring to molecular and anatomic pathology?, ADV ANAT PA, 8(1), 2001, pp. 14-20
Molecular cytogenetic alterations associated with rapid tumor cell proliferation in advanced urinary bladder cancer
Authors: Tomovska, S Richter, J Suess, K Wagner, U Rozenblum, E Gasser, TC Moch, H Mihatsch, MJ Sauter, G Schraml, P
Citation: S. Tomovska et al., Molecular cytogenetic alterations associated with rapid tumor cell proliferation in advanced urinary bladder cancer, INT J ONCOL, 18(6), 2001, pp. 1239-1244
Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers
Authors: Isler, SG Schenk, S Bendik, I Schraml, P Novotna, H Moch, H Sauter, G Ludwig, CU
Citation: Sg. Isler et al., Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers, INT J ONCOL, 18(3), 2001, pp. 521-526
Tree models for dependent copy number changes in bladder cancer
Authors: Schaffer, AA Simon, R Desper, R Richter, J Sauter, G
Citation: Aa. Schaffer et al., Tree models for dependent copy number changes in bladder cancer, INT J ONCOL, 18(2), 2001, pp. 349-354
Tissue microarray technology for high-throughput molecular profiling of cancer
Authors: Kallioniemi, OP Wagner, U Kononen, J Sauter, G
Citation: Op. Kallioniemi et al., Tissue microarray technology for high-throughput molecular profiling of cancer, HUM MOL GEN, 10(7), 2001, pp. 657-662
CGH, cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors
Authors: Heiskanen, M Kononen, J Barlund, M Torhorst, J Sauter, G Kallioniemi, A Kallioniemi, O
Citation: M. Heiskanen et al., CGH, cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors, ANAL CELL P, 22(4), 2001, pp. 229-234
Identification of a novel gene on chromosome 13 between BRCA-2 and RB-1
Authors: Schmidt, U Fiedler, U Pilarsky, CP Ehlers, W Fussel, S Haase, M Faller, G Sauter, G Wirth, MP
Citation: U. Schmidt et al., Identification of a novel gene on chromosome 13 between BRCA-2 and RB-1, PROSTATE, 47(2), 2001, pp. 91-101
Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization
Authors: El Gedaily, A Bubendorf, L Willi, N Fu, W Richter, J Moch, H Mihatsch, MJ Sauter, G Gasser, TC
Citation: A. El Gedaily et al., Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization, PROSTATE, 46(3), 2001, pp. 184-190
Improved procedure for fluorescence in situ hybridization on tissue microarrays
Authors: Andersen, CL Hostetter, G Grigoryan, A Sauter, G Kallioniemi, A
Citation: Cl. Andersen et al., Improved procedure for fluorescence in situ hybridization on tissue microarrays, CYTOMETRY, 45(2), 2001, pp. 83-86
ANX7, a candidate tumor suppressor gene for prostate cancer
Authors: Srivastava, M Bubendorf, L Srikantan, V Fossom, L Nolan, L Glasman, M Leighton, X Fehrle, W Pittaluga, S Raffeld, M Koivisto, P Willi, N Gasser, TC Kononen, J Sauter, G Kallioniemi, OP Srivastava, S Pollard, HB
Citation: M. Srivastava et al., ANX7, a candidate tumor suppressor gene for prostate cancer, P NAS US, 98(8), 2001, pp. 4575-4580
Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer
Authors: Monni, O Barlund, M Mousses, S Kononen, J Sauter, G Heiskanen, M Paavola, P Avela, K Chen, YD Bittner, ML Kallioniemi, A
Citation: O. Monni et al., Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer, P NAS US, 98(10), 2001, pp. 5711-5716
Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies
Authors: Bubendorf, L Nocito, A Moch, H Sauter, G
Citation: L. Bubendorf et al., Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies, J PATHOLOGY, 195(1), 2001, pp. 72-79
Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade
Authors: Nocito, A Bubendorf, L Tinner, EM Suess, K Wagner, U Forster, T Kononen, J Fijan, A Bruderer, J Schmid, U Ackermann, D Maurer, R Alund, G Knonagel, H Rist, M Anabitarte, M Hering, F Hardmeier, T Schoenenberger, AJ Flury, R Jager, P Fehr, JL Schraml, P Moch, H Mihatsch, MJ Gasser, T Sauter, G
Citation: A. Nocito et al., Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade, J PATHOLOGY, 194(3), 2001, pp. 349-357
Tissue microarrays (TMAs) for high-throughput molecular pathology research
Authors: Nocito, A Kononen, J Kallioniemi, OP Sauter, G
Citation: A. Nocito et al., Tissue microarrays (TMAs) for high-throughput molecular pathology research, INT J CANC, 94(1), 2001, pp. 1-5
High-throughout tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1)copy number alterations in urinary bladder cancer
Authors: Simon, R Richter, J Wagner, U Fijan, A Bruderer, J Schmid, U Ackermann, D Maurer, R Alund, G Knonagel, H Rist, M Wilber, K Anabitarte, M Hering, F Hardmeier, T Schonenberger, A Flury, R Jager, P Fehr, JL Schraml, P Moch, H Mihatsch, MJ Gasser, T Sauter, G
Citation: R. Simon et al., High-throughout tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1)copy number alterations in urinary bladder cancer, CANCER RES, 61(11), 2001, pp. 4514-4519
Tissue microarrays for rapid linking of molecular changes to clinical endpoints
Authors: Torhorst, J Bucher, C Kononen, J Haas, P Zuber, M Kochli, OR Mross, F Dieterich, H Moch, H Mihatsch, M Kallioniemi, OP Sauter, G
Citation: J. Torhorst et al., Tissue microarrays for rapid linking of molecular changes to clinical endpoints, AM J PATH, 159(6), 2001, pp. 2249-2256
CDKN2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas - Evidence for a second tumor suppressor gene proximal to CDKN2A
Authors: Schraml, P Struckmann, K Bednar, R Fu, WT Gasser, T Wilber, K Kononen, J Sauter, G Mihatsch, MJ Moch, H
Citation: P. Schraml et al., CDKN2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas - Evidence for a second tumor suppressor gene proximal to CDKN2A, AM J PATH, 158(2), 2001, pp. 593-601
Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis
Authors: Barlund, M Forozan, F Kononen, J Bubendorf, L Chen, YD Bittner, ML Torhorst, J Haas, P Bucher, C Sauter, G Kallioniemi, OP Kallioniemi, A
Citation: M. Barlund et al., Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis, J NAT CANC, 92(15), 2000, pp. 1252-1259
Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer
Authors: Tosoni, I Wagner, U Sauter, G Egloff, M Knonagel, H Alund, G Bannwart, F Mihatsch, MJ Gasser, TC Maurer, R
Citation: I. Tosoni et al., Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer, BJU INT, 85(1), 2000, pp. 48-53
Calretinin as a marker for cardiac myxoma - Diagnostic and histogenetic considerations
Authors: Terracciano, LM Mhawech, P Suess, K D'Armiento, M Lehmann, FS Jundt, G Moch, H Sauter, G Mihatsch, MJ
Citation: Lm. Terracciano et al., Calretinin as a marker for cardiac myxoma - Diagnostic and histogenetic considerations, AM J CLIN P, 114(5), 2000, pp. 754-759
Genetic chances in clinically organ-confined prostate cancer by comparative genomic hybridization
Authors: Fu, WT Bubendorf, L Willi, N Moch, H Mihatsch, MJ Sauter, G Gasser, TC
Citation: Wt. Fu et al., Genetic chances in clinically organ-confined prostate cancer by comparative genomic hybridization, UROLOGY, 56(5), 2000, pp. 880-885
Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients
Authors: Bubendorf, L Schopfer, A Wagner, U Sauter, G Moch, H Willi, N Gasser, TC Mihatsch, MJ
Citation: L. Bubendorf et al., Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients, HUMAN PATH, 31(5), 2000, pp. 578-583
Genetic and molecular markers of urothelial premalignancy and malignancy
Authors: Cordon-Cardo, C Cote, RJ Sauter, G
Citation: C. Cordon-cardo et al., Genetic and molecular markers of urothelial premalignancy and malignancy, SC J UROL N, 34, 2000, pp. 82-93
Risultati: 1-25 | 26-50 | 51-51